As Merck received its latest FDA nod for Keytruda in ovarian cancer, Agilent gained the green light for its accompanying test to identify patients who can best benefit from the drug. The test, PD-L1 ...

SANTA CLARA, Calif., February 04, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it will present a range of next‑generation automated workflow innovations at the ...

Sifting through countless of stocks in the Life Sciences Tools & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on ...

Agilent Technologies is a broad-based life science and analytical instrument company with a product portfolio spanning chromatography (GC/LC), mass spectrometry, spectroscopy, lab automation, vacuum ...

Agilent Technologies President and CEO Padraig McDonnell joins 'Mad Money' host Jim Cramer to talk quarterly results, where it is seeing growth opportunities, the type of research it is supporting and ...

Agilent stands out as a focused, well-managed leader in life science instruments, with strong financials and resilience amid global trade headwinds. The Ignite transformation program enhances supply ...

Agilent Technologies President and CEO Padraig McDonnell joins 'Mad Money' host Jim Cramer to talk quarterly results, its China business, GLP-1 drugs, and more. Got a confidential news tip? We want to ...

Agilent Technologies Inc. (NYSE:A) reported second-quarter 2025 sales of $1.67 billion on Wednesday, almost in line with the consensus of $1.63 billion, representing growth of 6% reported and up 5.3% ...

Feb 26 (Reuters) - Medical equipment maker Agilent (A.N), opens new tab lowered its annual revenue forecast on Wednesday, as it expects soft demand for its medical tools and equipment from smaller ...